Patrick Campbell

Results of the PARALLAX trial shed light on the effects of sacubitril/valsartan (Entresto) in patients with heart failure with preserved ejection fraction.

Results of the phase 3 EMPEROR-Reduced trial indicate the SGLT2 inhibitor empagliflozin was effective for patients with HFrEF regardless of whether the patients had diabetes or not.

An analysis of data from the New Bedford Cohort suggests exposure to endocrine-disrupting chemicals could increased risk of ADHD in adolescents.

Full data from the EVAPORATE trial presented at ESC Congress 2020 add further evidence of the cardiovascular benefits from use of icosapent ethyl.

A survey assessing burnout among nurses in Italy suggests more than one-third reported a high level of emotional exhaustion.

A meta-analysis examines the differences in HbA1c management, weight loss, and other factors associated with long- versus short-acting GLP-1 receptor agonists.

A pair of studies provides an overview of declines in use of cardiology services and patients presenting with adverse cardiovascular events during the pandemic.

A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age.

A look at nationwide data from an 11-year period gives physicians a greater understanding of predictors, trends, and outcomes associated with stroke in hypertensive disorders of pregnancy.

New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.

Quitting smoking at the time of an Afib diagnosis could reduce risk of incident stroke event by 28%, according to a new analysis from ESC 2020.

A study presented at ESC found the recommendation of deep chest compressions in 2010 CPR guidelines increased the incidence of CPR-related injury but also helped preserve brain function in patients.

Using data from a group of RCTs, investigators determined semaglutide was associated with greater reductions in HbA1c and weight loss than empagliflozin.

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

An analysis of more than 3 million Europeans receiving an antihypertensive medication indicates medications for high blood pressure were not linked to an increase in risk of depressive disorders.

A physician from New York City discusses her experiences treating and suffering from coronavirus disease 2019 (COVID-19) during her work at a medical intensive care unit at Mount Sinai.

Analysis of 2500 women indicates hypertensive disorders of pregnancy increased the risk of experiencing menopausal symptoms later in life.

An analysis of data from a Society of Vascular Surgeons registry is shedding light on the use of DAPT in patients following peripheral vascular interventions.

An analysis of more than 650 women found increased intake of cruciferous vegetables, such as cauliflower and broccoli, was linked to lower odds of severe abdominal aortic calcification.

Full results of the phase 3 ELIPSE HoFH offer the greatest overview yet of the effects of evinacumab in patients with homozygous familial hypercholesterolemia.

A study comparing 22 patients is offering a detailed overview of the effects of weight loss as a result of gastric bypass surgery and diet alone in obese patients.

An analysis of Medicare patient data suggest use of intravascular ultrasound during PCI could reduce long-term mortality risk.

New research is shedding light on the association between a history of hypertensive disorder of pregnancy and risk of menopausal symptoms later in life.

An analysis of NHANES data suggests those who lost weight between early adulthood and midlife could have drastically reduced their risk of mortality.

A professor from Michigan Medicine discusses recent research from the institute and how protocols implemented at Michigan Medicine to manage the increased risk of severe outcomes associated with hyperglycemia in COVID-19.

An analysis of data from England details the increased odds of mortality associated with type 1 and type 2 diabetes in COVID-19 patients.

An analysis of more than 20 studies and 70k patients details the impact cardiovascular risk factors and complications can have on outcomes in patients hospitalized with COVID-19.

New data suggests sex hormone levels could help predict development of heart failure in older men and postmenopausal women.

A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.

A professor of pharmacy from Colorado offers an overview of marijuana and cardiovascular health based on current research and also addresses areas in need of the most research going forward.